Search results
Judgment of the Court of First Instance (Fifth Chamber, extended composition) of 26 October 2000. # Bayer AG v Commission of the European Communities.
Bayer AG v Commission of the European Communities. Competition - Parallel imports - Article 85(1) of the EC Treaty (now Article 81(1) EC) - Meaning of "agreement between undertakings" - Proof of the existence of an agreement - Market in pharmaceutical products.
BAI and Commission v Bayer Notes on Academic Writings Koenigs, Folkmar: Vorliegen einer gegen den EG-Vertrag verstoßenden Vereinbarung über ein wettbewerbsbeschränkendes Verhalten?, Der Betrieb 2004 p.249 (DE)
Case 26/76 Metro SB-Großmärkte GmbH & Co. KG v Commission of the European Communities (1977) ECR -01875; Competition law, private undertakings, application for a finding that an infringement has occured, dominant position on the market. Full Lisbonised Judgment.
Summary of the Judgment 1. Competition — Agreements, decisions and concerted practices — Agreements between undertakings — Meaning — Bilateral or multilateral conduct — Included — Uni lateral conduct — Not included — Conduct appearing unilateral — Need to prove acquiescence by other undertakings in that conduct
4 sty 2024 · Bayer AG v Commission [1996] Case T-41/96 R. Bayer made and marketed medical drug intended to treat heart disease. As result of differences between national health authorities of MS, prices of these drugs were different across EU, lower in France and Spain.
1. CASE SUMMARY A. Summary of facts. Bayer manufactured and marketed under the trade name ‘Adalat’ a range of medicinal preparations. Bayer adopted measures to limit exports of Adalat by wholesalers from France and Spain to the United Kingdom (‘UK’).
